Recent developments with Kiniksa Pharmaceuticals International Plc (KNSA) have led to the company’s beta value being reach 0.16 cents.
On Tuesday, Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) was -0.15% drop from the session before settling in for the closing price of $20.05. A 52-week